BiomX Inc.
Develops phage therapies to target harmful bacteria in chronic diseases like cystic fibrosis.
PHGE | NYSE
Overview
Corporate Details
- ISIN(s):
- US09090D1037
- LEI:
- Country:
- United States of America
- Address:
- 22 EINSTEIN ST., 7414003 NESS ZIONA
- Website:
- https://www.biomx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BiomX Inc. is a clinical-stage biopharmaceutical company specializing in the development of phage therapies to combat chronic diseases. The company develops natural and engineered phage cocktails and personalized treatments designed to precisely target and destroy harmful bacteria. Its therapeutic pipeline addresses conditions including cystic fibrosis and diabetic foot osteomyelitis. BiomX's proprietary platform, founded on technology from the Weizmann Institute of Science and MIT, enables the discovery of novel bacterial targets and the customization of corresponding phage compositions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BiomX Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BiomX Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BiomX Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
